US visa changes to affect mainly Russian independent travelers, says authorityBusiness & Economy August 21, 21:07
CAS upholds life ban for ex-president of Russian athleticsSport August 21, 20:03
Police confirms man shot dead in Subirats was Barcelona attack perpetratorWorld August 21, 19:50
Premiere for historical drama Matilda rescheduled for late OctoberSociety & Culture August 21, 19:45
Fire in Russia’s Rostov-on-Don fully containedWorld August 21, 19:37
Russia wins two golds on second day of 2017 Universiade in TaipeiSport August 21, 19:29
Washington’s new strategy in Afghanistan aimed against China, expert saysWorld August 21, 18:43
Russia settles last part of Soviet debtBusiness & Economy August 21, 18:37
Man wearing suicide belt shot dead near BarcelonaWorld August 21, 18:29
MOSCOW, June 19. /ITAR-TASS/. Russian pharmaceutical producer R-Pharm will invest €30 million in constructing a biotechnological plant in Turkey, CEO Vasily Ignatyev said late on Wednesday.
In 2013, R-Pharm established a joint venture with a Turkish partner aimed at selling R-Pharm’s medicines in Turkey, the Middle East and the northern Africa.
“We hope to get all necessary documents for clearance until the end of the year and to start the earthworks. We plan to finish the construction and to set up equipment until the end of 2016. The commercial launch will be made, as we expect, in late 2017,” Ignatyev said.
R-Pharm will invest €100 million in its Turkish business until 2018, he said.
Ignatyev separately said that the company will close the deal to purchase a plant from a large pharmaceutical company in Germany until the end of 2014.